Literature DB >> 17212686

Bayard Horton's clinicopathological description of giant cell (temporal) arteritis.

C J Boes1.   

Abstract

The author set out to review the thought processes of Bayard Horton as he was clinicopathologically describing the first cases of temporal arteritis. The Mayo Clinic records of the original temporal arteritis patients were examined. Horton obtained the first biopsies of the temporal arteries in temporal arteritis and was the first to describe the histopathology. Horton initially thought his first two patients had actinomycosis of the temporal arteries, but later abandoned this diagnosis. He reported these two patients in 1932 as 'an undescribed form of arteritis of the temporal vessels'. He was the first to describe jaw claudication. He saw a patient with blindness and symptoms suggestive of temporal arteritis before this complication was described in the literature, but initially felt the patient had some other disease. The sedimentation rate was elevated in his first patient. He cared for the first temporal arteritis patient ever treated with cortisone.

Entities:  

Mesh:

Year:  2007        PMID: 17212686     DOI: 10.1111/j.1468-2982.2007.01238.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  6 in total

1.  Morphological features of temporal arteritis.

Authors:  William C Roberts; Saleha Zafar; Jo Mi Ko
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

Review 2.  EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice summary.

Authors:  Mohammad Bardi; Andreas P Diamantopoulos
Journal:  Radiol Med       Date:  2019-06-28       Impact factor: 3.469

Review 3.  The immunopathology of giant cell arteritis: diagnostic and therapeutic implications.

Authors:  Cornelia M Weyand; Y Joyce Liao; Jörg J Goronzy
Journal:  J Neuroophthalmol       Date:  2012-09       Impact factor: 3.042

4.  Horton's disease: still an important medical problem in elderly patients: a review and case report.

Authors:  Krzysztof Gomułka; Joanna Radzik-Zając; Urszula Zaleska-Dorobisz; Bernard Panaszek
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

Review 5.  Biologic Therapies for Giant Cell Arteritis.

Authors:  Robert Harrington; Shamma Ahmad Al Nokhatha; Richard Conway
Journal:  Biologics       Date:  2021-01-06

Review 6.  Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.

Authors:  Andriko Palmowski; Frank Buttgereit
Journal:  Curr Rheumatol Rep       Date:  2020-10-12       Impact factor: 4.592

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.